Dr. Shiran Shapira and Nano24 Shine at Falling Walls Venture

"Falling Walls Venture" is a global platform showcasing the entrepreneurial potential of science. This format provides a stage for groundbreaking startups that have successfully transformed science into business, demonstrating how their solutions can address today’s most pressing challenges. At "Falling Walls Venture", startups present their work to a distinguished audience of investors, scientists, business leaders, and policymakers. The primary focus is on groundbreaking scientific ideas that are innovative, commercially viable, and have the potential to create a positive impact.

Selected startups from around the world are nominated by leading universities and research institutions, giving them the opportunity to compete for recognition as the most promising science venture. This year, over 1,100 breakthrough technologies were submitted by 300 institutions worldwide. The most promising companies were meticulously selected by an advisory committee and high-level judges—international experts, investors, and corporate innovation leaders.

The event serves as a bridge between science, business, and society, helping startups connect with potential partners and investors while amplifying their impact on the world.  

This year, Nano24, a spin-off company founded by Prof. Nadir Arber and Dr. Shiran Shapira, showcased its groundbreaking technology for treating a variety of cytokine storm- related diseases with no medical therapy," on stage in Germany. A remarkable achievement!